Theolytics announces first patient dosed in the Octopod‑IP trial
28th April 2026 Uncategorised 0US study marks company’s second clinical trial of ovarian cancer therapy More: Theolytics announces first patient dosed in the Octopod‑IP trial Source: News
read more
